Northera-01 (Northera 1)
Northera Capsule
Product Images NDC 67386-822
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Northera (NDC 67386-822). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lundbeck Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Mean Change In Ohsa (Northera 2)
Baseline Value = 5.1, Units In Both Groups. Droxidopa administered for 3, 4, 5, and 7 weeks in the double-blind treatment phase.*
Distribution Of Patients By Change In Ohsa (Northera 3)
This appears to be a graph depicting the improvement in OHSA question 1 with placebo and drovidopa treatment. The x-axis shows scores ranging from 1-6, with 1 being worse and 6 being better. The y-axis displays the percentage of subjects with each score. The graph shows that a higher percentage of subjects on drovidopa experienced improvement in OHSA question 1 compared to placebo.*
Northera 100 mg (Northera 4)
This is a medication information sheet for Northera capsules, which contain droxidopa. The recommended temperature range for storage and dispensing is between 15°C and 30°C. The medication should be kept in a tightly sealed, light-resistant container and not used if the printed seal is broken. There is a warning to keep the medication out of reach of children. The manufacturer is Patheon in Canada, and it is distributed by Lundbeck in Deerfield, Illinois. The text includes an NDC code for the medication but does not provide specific usage instructions beyond referring to the prescribing information.*
Northera 200 mg (Northera 5)
This text seems to be a label or package insert for a medication called "Northera" (droxidopa) capsules with a strength of 200 mg. The label includes instructions for storage, dispensing, and a warning to keep the container out of reach of children. The medication was manufactured by Patheon in Canada and distributed by Lundbeck in the USA. The purpose of the medication is not explicitly stated.*
Northera 300 mg (Northera 6)
This is a label for a medication called Northera™, specifically for the 90 capsule format. The label includes information on the temperature range for storage and a caution about not using the medication if the seal under the cap is broken or missing. The label also contains information on prescribing the medication and a reminder to keep it out of reach of children.*
Northera 7
This is a description of a medication called "Droxidopa" which comes in a bottle of 90 capsules. Each capsule contains 100mg of Droxidopa. The recommended storage temperature range is from 0°C to 75°C. The medication should be kept out of reach of children. It is manufactured by Paladin Labs in Canada and distributed by Lunbeck in the US. The name of the medication is written as "Dravidapa" in the text, which may be a result of an error.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
